Skip to main
GRDN
GRDN logo

GRDN Stock Forecast & Price Target

GRDN Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Guardian Pharmacy Services Inc. has demonstrated robust growth, tripling the number of residents served since 2014, with a notable 41% increase in residents served since 2020, largely driven by organic growth. The company's strategic positioning is underscored by strong market share within the assisted living facilities (ALFs) and memory care (MC) segments, with 32 out of 39 pharmacies achieving leading market share in their respective metropolitan statistical areas. Additionally, Guardian's solid financial flexibility, characterized by minimal net leverage and strong cash flow generation, combined with ongoing investments in platform enhancements, positions the company favorably for sustained growth in a market projected to expand at over 5% CAGR through 2030.

Bears say

The financial analysis indicates a negative outlook for Guardian Pharmacy Services Inc due to several fundamental risks. First, the potential inability to compete effectively or loss of market share, coupled with disruptions in the supply chain, poses significant threats to both growth and profitability. Additionally, anticipated changes from the Inflation Reduction Act, along with challenges in acquiring and integrating new businesses, may further hinder the company's ability to drive patient growth and maintain a favorable financial trajectory, warranting concern over its future performance in a highly regulated industry.

GRDN has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Guardian Pharmacy Services Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Guardian Pharmacy Services Inc (GRDN) Forecast

Analysts have given GRDN a Buy based on their latest research and market trends.

According to 2 analysts, GRDN has a Buy consensus rating as of Jul 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $24.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $24.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Guardian Pharmacy Services Inc (GRDN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.